Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

Lexicon (LXRX) announced The Lancet Diabetes & Endocrinology has published a research paper analyzing the ability of sotagliflozin, a dual ...

The results showed that people who took sotagliflozin had a 23% lower risk of heart attacks, strokes, and death from ...

Research shows short-term fasting improves glucose regulation, while long-term fasting in young mice impairs β cell function, ...

Experts are now calling for NHS guidance - which does not recommend managing diabetes with different drugs depending on age - ...

All sexually transmitted diseases (STDs) start as sexually transmitted infections (STIs). Knowing the incubation period for the most common infections can help you determine when to get tested ...

Sodium-glucose cotransporter 2 (SGLT2) inhibitors work by inhibiting glucose reabsorption in the kidney and are also being tested in individuals with type 1 diabetes. These agents provide insulin ...

Other factors, like drug interactions, improper dosage, or changes in lifestyle, can also affect how the drug works. How long does it take metformin to lower blood sugar? Metformin may lower blood ...

Cardiorenal effects of SGLT2 and incretin agents SGLT2 inhibitors work directly on the kidney through ... As previously mentioned, BMI does correlate grossly with visceral fat but is not sensitive ...

In addition to paying for injuries and rehabilitation, workers’ compensation may compensate a family after a work-related death ... If the employer does not dispute the claim, the insurance ...

Adults with overweight or obesity and type 2 diabetes who are given the sodium glucose cotransporter 2 (SGLT-2) inhibitor drug dapagliflozin ... for the submitted work; no financial relationships ...